Market Overview

Global Anti-Viral Therapeutics Market Analysis, Growth, Trends & Forecasts 2018-2023, With an Expected CAGR of 6.2% - ResearchAndMarkets.com

Share:

The "Global
Anti-Viral Therapeutics Market - Segmented by Drug Type, Distribution
Channel and Geography - Growth, Trends and Forecasts (2018 - 2023)"

report has been added to ResearchAndMarkets.com's
offering.

The global anti-viral Therapeutics market is expected to register a CAGR
of 6.2% during the forecast period, 2018 to 2023.

According to the World Health Organization (WHO), it is estimated that
in 2015, nearly 36.7 million individuals had HIV. It has been identified
that most of this prevalence is in low and middle-income countries.
According to UNAIDS in 2016, around 1.8 million people with new HIV
infection were reported worldwide. In 2017, 20.9 million people were
accessing antiretroviral therapy, globally. The huge patient pool
indicates high demand for anti-viral drugs, which will likely drive the
market growth during the forecast period.

Therapeutics losing patent exclusivity affects the market largely. Along
with the innovator company, there are many regional/local players in the
market. Due to this, the prices of the Therapeutics come down rapidly
and the overall market gets affected.

North America dominates the global anti-viral Therapeutics market owing
to the presence of well-established market players, and growing
prevalence of HIV and Hepatitis C infections. Asia-Pacific is expected
to grow tremendously during the forecast period owing to factors, such
as high prevalence of HIV infection, growing awareness regarding HIV
infection, and increasing collaboration between public and private
sectors to provide affordable treatment to the low and middle-income
countries.

Companies Mentioned

  • Abbvie Inc.
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc
  • Glaxosmithkline Plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi
  • Johnson & Johnson

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/qzk2dw/global_antiviral?w=4

View Comments and Join the Discussion!